Combined analysis of network pharmacology and transcriptomics deciphers the pharmacological mechanism of Huangqi Guizhi Wuwu decoction attenuates oxaliplatin-induced peripheral neuropathy via regulating Sirt1
Journal of Ethnopharmacology · 2026
DOI: 10.1016/j.jep.2025.120486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2026. Verfasst von Runwen Mao und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese M…. Hauptthemen laut MEDLINE: Oxaliplatin, Sirtuin 1, Drugs, Chinese Herbal, Peripheral Nervous System Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Jiangsu Provincial Key Research and Development Program, National Natural Science Foundation of China, China Academy of Chinese Medical Sciences.
Abstract (Originalsprache)
ETHNOPHARMACOLOGICAL RELEVANCE: Huangqi Guizhi Wuwu decoction (HGWD) is firstly recorded in the ancient Chinese ethnomedical manuscript "Synopsis of the Golden Chamber" with nourishing qi and blood for the treatment of limb numbness and ache in patients. Nowadays, accumulating evidence suggests that it could effectively alleviate symptoms of pain in oxaliplatin-induced peripheral neuropathy (OIPN). However, the therapeutic mechanism of HGWD against OIPN is necessary to be further clarified. METHODS: The mice model of OIPN was established using the behavioral tests and histopathological observation to assess the therapeutic effect of HGWD against OIPN in vivo. The UHPLC-ESI-Q-TOF-MS/MS was used to identify the potential bioactive components from HGWD in drug-containing rat plasma. The integrated network pharmacology and transcriptomics strategy was performed to deciphers the mechanism of HGWD against OIPN with experimental verification. RESULTS: HGWD could improve pain sensitivity symptom and alleviate the damage of dorsal root ganglia (DRG) neurons or intraepidermal nerve fibers in the mice model of OIPN. Through the integrated analysis of transcriptome and network pharmacology, Sirtuin 1 (Sirt1) was considered as the vital target for HGWD against OIPN. Via virtual screening and the ND7 cell viability assay, Formononetin (FN) and Oxypaeoniflorin (OPRA) from HGWD showed preliminary neuroprotective effects. In addition, OPRA can reduce Sterile alpha and toll interleukin receptor motif-containing protein 1 (SARM1) levels, improve axonal degeneration, and alleviate OIPN through the Sirt1 pathway. CONCLUSION: HGWD could effectively alleviate the pain and nerve injury symptoms in mice with oxaliplatin-induced peripheral neuropathy. The therapeutic mechanism of HGWD against OIPN was relevant to the Sirt1 for the function of anti-oxidative stress in DRG. OPRA can reduce SARM1 levels, improve axonal degeneration, and alleviate OIPN through the Sirt1 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, 210023, China; College of Pharmacy, Nanjing Universi…
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210029, China; Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, C…
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210029, China.
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, China.
- State Key Laboratory of Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, 210023, China; Affiliated Hospital of Integrated Tra…
Förderung
- Jiangsu Provincial Key Research and Development Program
- National Natural Science Foundation of China
- China Academy of Chinese Medical Sciences
- Jiangsu Provincial Medical Center
Zitieren
APA
Mao, R., Shen, J., Wu, Y., Wang, Y., Dai, J., Fan, H., Lv, Z., Cheng, X., Gao, X., & Cao, P. (2026). Combined analysis of network pharmacology and transcriptomics deciphers the pharmacological mechanism of Huangqi Guizhi Wuwu decoction attenuates oxaliplatin-induced peripheral neuropathy via regulating Sirt1. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.120486
Vancouver
Mao R, Shen J, Wu Y, Wang Y, Dai J, Fan H, et al. Combined analysis of network pharmacology and transcriptomics deciphers the pharmacological mechanism of Huangqi Guizhi Wuwu decoction attenuates oxaliplatin-induced peripheral neuropathy via regulating Sirt1. Journal of Ethnopharmacology. 2026. doi:10.1016/j.jep.2025.120486
BibTeX
@article{Mao2026,
author = {Mao, Runwen and Shen, Jiayun and Wu, Yuze and Wang, Yue and Dai, Jingya and Fan, Haizhen and Lv, Zhangming and Cheng, Xiaolan and Gao, Xuejiao and Cao, Peng},
title = {Combined analysis of network pharmacology and transcriptomics deciphers the pharmacological mechanism of Huangqi Guizhi Wuwu decoction attenuates oxaliplatin-induced peripheral neuropathy via regulating Sirt1},
journal = {Journal of Ethnopharmacology},
year = {2026},
doi = {10.1016/j.jep.2025.120486}
}
EUVIMED